Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D46IVH
|
|||
| Drug Name |
GTX-102
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Angelman syndrome [ICD-11: LD90.0; ICD-10: Q93.5] | Phase 1/2 | [1] | |
| Company |
GeneTx Biotherapeutics Sarasota, FL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04259281) A Phase 1/2 Open-label, Multiple-dose, Dose-escalating Clinical Trial of the Safety and Tolerability of GTX-102 in Pediatric Patients With Angelman Syndrome (AS). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.